Arcadia Biosciences
NASDAQ: RKDADallas, US · Founded 2002 · Delaware corporation · 29 employees on LinkedIn
Find your way into Arcadia Biosciences
233 people in our graph share verified history with the Arcadia Biosciences team — schools, employers, funds. One of them is your warm intro.
Matt Plavanunlockedknows Rajendra Ketkar · together at Arcadia Biosciences (overlapped)
knows the team · via Arcadia Biosciences
×10knows the team · via Monsanto
Arcadia Biosciences develops specialty wheat ingredients with enhanced nutritional profiles — such as higher fiber, improved protein, reduced gluten, and longer shelf life — working with food manufacturers and processors to reformulate wheat-based products. The company also markets Zola coconut water, a consumer beverage brand.
Founders & leadership
TJ
Thomas J. SchaeferExecutive
MT
Matthew T PlavanExecutive
RK
Rajendra KetkarPresident and CEO2016–2019Rajendra Ketkar served as President and CEO of Arcadia Biosciences, where he oversaw technology repositioning, product commercialization, and capital raising. His prior experience includes regional leadership roles in Asia, product launches across seeds and agricultural biotechnology, and oversight of manufacturing and research operations.
MW
Mark WongExecutive
JR
James ReisExecutive
UG
Uday GargNamed on SEC filing
ER
Eric RayNamed on SEC filing
Board
DS
Darby ShuppBoard director
DC
Deborah CarosellaBoard director
GD
Gregory D. WallerBoard director
LS
Lilian Shackelford MurrayBoard director
Reported raises · per SEC filings
Form D private placements$60M disclosed across 5 rounds · 2014–2026
▶$4MraisedJun 2026 · 5 investors · Other TechnologyRule 506(b)
▶$4MraisedJun 2026 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Amy YoderDirector
- Lilian Shackelford MurrayDirector
- Gregory D WallerDirector
- Kevin ComcowichDirector
- Thomas J. SchaeferExecutive Officer, Director
- Offering amount
- $11.4M
- Amount sold
- $4M
- Sales commissions
- $395K
- Placement agents
- H.C. Wainwright & Co, LLC
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedJan 2026 · 3 investors · Other TechnologyRule 506(b)
▶$2.1MraisedJan 2026 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Deborah CarosellaDirector
- Gregory D. WallerDirector
- Lilian Shackelford MurrayDirector
- Amy YoderDirector
- Thomas J. SchaeferExecutive Officer, Director
- Albert D. BollesDirector
- Kevin ComcowichDirector
- Offering amount
- $6M
- Amount sold
- $2.1M
- Sales commissions
- $145.7K
- Placement agents
- H.C. Wainwright & Co, LLC
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedFeb 2021 · 26 investors · Other TechnologyRule 506(b)
▶$25MraisedFeb 2021 · 26 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin ComcowichDirector
- Albert D BollesDirector
- Lilian Shackelford MurrayDirector
- Gregory D WallerDirector
- Amy YoderDirector
- Matthew T PlavanExecutive Officer, Director
- Pam HaleyExecutive Officer
- Offering amount
- $25M
- Amount sold
- $25M
- Sales commissions
- $1.8M
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedApr 2018 · 2 investors · Other TechnologyRule 506(b)
▶$10MraisedApr 2018 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew T PlavanExecutive Officer
- Amy YoderDirector
- Gregory D WallerDirector
- Kevin ComcowichDirector
- Uday GargDirector
- Rajendra KetkarExecutive Officer, Director
- Eric RayDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Finders' fees
- $700K
- Placement agents
- H.C. Wainwright & Co. LLC
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.9MraisedApr 2014 · 8 investors · Other TechnologyRule 506(b)
▶$18.9MraisedApr 2014 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Uday GargDirector
- Darby ShuppDirector
- Steven BrandweinDirector
- Eric J. ReyExecutive Officer, Director
- Mark WongDirector
- Rachel SheinbeinDirector
- James ReisDirector
- Offering amount
- $35.5M
- Amount sold
- $18.9M
- Minimum investment
- $10K
- Sales commissions
- $2M
- Placement agents
- Piper Jaffray & Co.
- First sale
- Mar 2014
- Incorporated
- Corporation, Arizona
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$345.9Mvaluation at IPOMay 2015 · $8.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 2
by search overlap
Robinhood16 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TradingView15 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with Arcadia Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Agriculture (USDA) | Phase I | 2017 | $100K |
| Department of Agriculture (USDA) | Phase II | 2016 | $600K |
| Department of Agriculture (USDA) | Phase I | 2016 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2015 | $1.3M |
| Department of Agriculture (USDA) | Phase I | 2015 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2013 | $689.5K |
| National Science Foundation | Phase I | 2013 | $150K |
| Department of Agriculture (USDA) | Phase I | 2013 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2011 | $874.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $144.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2009 | $855.6K |
| Department of Agriculture (USDA) | Phase I | 2007 | $79.9K |
| Department of Agriculture (USDA) | Phase I | 2006 | $79.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2005 | $98.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Arcadia Biosciences has filed a notice of an exempt offering of securities to raise $11,417,964.00 in New Funding. - intelligence360intelligence360.news · Jul 2026
RKDA Secures $4 Million in Private Placement Funding | BioPharmaWbiopharmawatch.com · Jun 2026
Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options | Quiver Quantitativequiverquant.com · Jun 2026Frequently asked questions
- What does Arcadia Biosciences do?
- Arcadia Biosciences develops specialty wheat ingredients with enhanced nutritional profiles — such as higher fiber, improved protein, reduced gluten, and longer shelf life — working with food manufacturers and processors to reformulate wheat-based products. The company also markets Zola coconut water, a consumer beverage brand.
- How much funding has Arcadia Biosciences raised?
- Arcadia Biosciences has disclosed $60M raised across 5 rounds.
- Where is Arcadia Biosciences headquartered?
- Arcadia Biosciences is headquartered in Dallas, US.